🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

9 recruiting trials

for PFIC - Progressive Familial Intrahepatic Cholestasis

Long-Term SafEty and Clinical Outcomes of LivmArli in Patients in the United States (LEAP-US) NCT06193928n/a8 sites📍 Los Angeles📍 Aurora📍 Atlanta Mirum Pharmaceuticals, Inc. · Tests: Livmarli, Livmarli A Study of the Effectiveness, Safety and the Long-term Outcomes of Participants With Progressive Familial Intrahepatic Cholestasis (PFIC) Who Take Odevixibat (Bylvay) in South Korea NCT07185919n/a5 sites📍 Gyeongsang📍 Seoul📍 Seoul Ipsen A Database Study of Maralixibat (TAK-625) in Participants With Alagille Syndrome (ALGS) and Progressive Familial Intrahepatic Cholestasis (PFIC) NCT07293897n/a1 site📍 Tokyo Takeda · Tests: Maralixibat Prospective Analysis of the Treatment of Progressive Familial Intrahepatic Cholestasis (TreatFIC) NCT06778174n/a1 site📍 Groningen University Medical Center Groningen · Tests: observational study Dental Dyschromia and Quality of Life in Early Prolonged Hyperbilirubinemia NCT06506734n/a9 sites📍 Bordeaux📍 Caen📍 Lille University Hospital, Toulouse · Tests: Questionnaires Familial Intrahepatic Cholestasis-related Genes Associated with Disease Susceptibility in Hepato-biliary Cancers NCT06777914n/a5 sites📍 Bologna📍 Bologna📍 Bologna IRCCS Azienda Ospedaliero-Universitaria di Bologna Pediatric Evaluation and Registry for Liver Cholestasis in Canada NCT07411716n/a13 sites📍 Calgary📍 Edmonton📍 Vancouver Children's Hospital of Eastern Ontario Long-Term Low-Intervention SafEty and Clinical Outcomes Clinical Study of LivmArli® in Patients With Alagille Syndrome or Progressive Familial Intrahepatic Cholestasis in the European Union (LEAP-EU) NCT07290257Phase 415 sites📍 Brussels📍 Ghent📍 Bron Mirum Pharmaceuticals, Inc. · Tests: Livmarli Oral Product A Study of the Effectiveness, Safety and the Long-term Outcomes of Participants With Progressive Familial Intrahepatic Cholestasis (PFIC) Who Take Odevixibat (Bylvay) in China NCT07588880n/a6 sites📍 Beijing📍 Chongqing📍 Hunan Ipsen
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy